Thermo Fisher Scientific Inc (NYSE:TMO) over-valued by 9%
Website | https://www.thermofisher.com/ |
Sector | Healthcare |
Industry | Diagnostics & Research |
Fiscal Year End | Dec 31, 2019 |
Market Cap | $173,347,095,000 |
Beta | 0.98463 |
Average Volume | $1,287,609 |
Last Dividend | 0.79% |
Price on Jul 31, 2020 | $428.39 |
Autochartist™ Valuation | $390.89 |
Conclusion |
9% over-valued |
Download Report |